TSHA — Taysha Gene Therapies, Inc. stock price, charts and financials

QT61Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.02
-0.14-2.71%
OverviewShort InterestFilings
TSHAQT61Taysha Gene Therapies, Inc.·NASDAQ
5.02-2.71%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 202610-QQuarterly report
Aug 11, 20268-KCurrent report
Jul 10, 20264Statement of changes in beneficial ownership
Jun 25, 2026424B5Prospectus
Jun 25, 20268-KCurrent report
Jun 24, 2026424B5Prospectus
Jun 22, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 20268-KCurrent report
May 06, 202610-QQuarterly report
Apr 22, 2026ARSAnnual report to shareholders
Apr 22, 2026DEFA14AAdditional proxy soliciting materials
Apr 22, 2026DEF 14ADefinitive proxy statement
Apr 13, 20264Statement of changes in beneficial ownership
Mar 19, 20268-KCurrent report
Mar 19, 202610-KAnnual report
Feb 17, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 280
Page
▼
/ 12